title: Long-term Karnofsky performance status and neurological outcome in patients with neurohypophyseal germinomas.
abstract: Long-term posttreatment Karnofsky Performance Status (KPS) and neurological status of 16 patients with neurohypophyseal (NH) germinomas were retrospectively analysed, in order to deduce the best treatment modality to achieve a good outcome. The average age at treatment was 15.5 years (rouge 6-26) and they were followed up for 107.3 months (26-209). The KPS averaged 81.5 (0-100). Three patients were below 60 in the KPS. The first one had hemiparesis due to a delayed cerebrovascular accident (CVA), and the second became indifferent and inactive with recent memory loss. The third died from marginal recurrence of tumour and subsequent systemic metastasis. The low scores were all more or less attributable to complications related to irradiation: delayed CVA, diffuse cortical atrophy and inappropriate selection of irradiation field, respectively. The second case had the tumour origin at the hypothalamus, which indicates intraparenchymal tumour location as another factor to worsen the quality of life (QOL). Visual field and acuity, and EOM impairment were observed in eight and five patients, respectively. It improved in all patients but one. The visual and EOM dysfunction recovered satisfactorily and was not a disabling factor. The intraparenchymal lesion resulting in hemiparesis and higher cortical dysfunction due to either irradiation-related complications or tumour invasion is a major determining factor of lower KPS. Irradiation related complications are considered to be avoidable by reducing radiation dosage with appropriate chemotherapy and/or proper selection of irradiation field. Patients with smaller tumour size of less than 20 mm had higher KPS. Accordingly, repeated studies of tumour markers and neuroimages are required in patients with idiopathic diabetes insipidis, in order to detect the tumour, if present, at the small-sized and early stage.
authors.affiliation: Department of Neurological Surgery, Chiba University School of Medicine, Japan. saeki@med.m.chiba-u.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Saeki
authors.forename: H
authors.initials: H
authors.lastname: Murai
authors.forename: M
authors.initials: M
authors.lastname: Kubota
authors.forename: N
authors.initials: N
authors.lastname: Fujimoto
authors.forename: A
authors.initials: A
authors.lastname: Yamaura
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D018237:Germinoma / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D010904:Pituitary Gland, Posterior; D010911:Pituitary Neoplasms / Q000503:physiopathology / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D016896:Treatment Outcome; D014786:Vision Disorders / Q000209:etiology; D014794:Visual Fields / Q000502:physiology